Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,559 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07167043Enrolling by invitation
AI assistant for reading brain CT and MRI scans
This study tests an AI system that helps doctors read brain CT and MRI scans. If you had a brain scan for possible tumors, stroke, injury, or other conditions, your data could be used to improve this tool.
BeijingAges Any age - NCT07167537RecruitingPhase 1
Study of OL-CD19-GDT for hard-to-treat autoimmune diseases
This trial tests a new treatment called OL-CD19-GDT for people with systemic sclerosis or Sjögren's syndrome that hasn't responded to standard therapies. It aims to see if the treatment is safe and might help control the disease.
BeijingAges 18–65 - NCT07171164Recruiting
Community-based ways to boost RSV vaccine use in Latino adults
This study looks at community-based ways to help Latino adults ages 50 and older in San Francisco and Daly City get the RSV vaccine. The goal is to learn what works best to increase vaccination rates.
San Francisco, CaliforniaAges 18 years+ - NCT06201403Recruiting
COPD: Breathing Muscle Strength and Flexibility Study
This study looks at the strength and flexibility of muscles you use to breathe, including muscles in your chest and neck. If you have moderate-to-severe COPD and have been stable on your medications, it may help researchers understand how these muscles are affected.
Istanbul, ZeytinburnuAges 18–75 - NCT06790368Recruiting
Venom allergy treatment in real-life settings
This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.
Alcorcón, MadridAges 14 years+ - NCT06954519Recruiting
Mental imagery training for anesthesia residents
This trial tests if practicing mental imagery helps anesthesia residents improve their non-technical skills, like communication and teamwork, during procedures. If you are an anesthesia resident in your first through fourth year of training, you may be able to join.
Reims, Grand EstAges 18–30 - NCT05977088Recruiting
Testing rTMS to help memory in Alzheimer’s
This study tests whether a brain stimulation treatment called rTMS can improve symptoms in people with Alzheimer’s disease. It mainly looks at people with mild to moderate dementia and checks whether results differ based on how the treatment is applied.
IstanbulAges 55 years+ - NCT07163819RecruitingPhase 2
Probiotics for digestive health during short trips abroad
This study tests whether taking a probiotic can help prevent or reduce digestive issues when traveling abroad for less than a week. It aims to see if probiotics support overall health during short overseas trips.
Haidian, Beijing MunicipalityAges 18–65 - NCT07163156Enrolling by invitation
Prolactin and inflammation in Parkinson's severity
This study looks at whether prolactin (a hormone) and inflammation markers in blood and saliva are related to the severity of Parkinson's disease. It may help identify new ways to track the disease.
Çanakkale, MerkezAges 18 years+ - NCT07161479Recruiting
Comparing two ways to remove small stomach growths
This study compares two ways to remove tiny, non-cancerous stomach growths—using a gentle heat tool (argon plasma coagulation) or a special scope to cut them out. The goal is to see which method is safer and works better.
Goyang-siAges 20 years+ - NCT07160205RecruitingPhase 2/Phase 3
Study of ULSC for dermatomyositis and polymyositis
This trial tests a new treatment called ULSC to see if it can improve muscle strength and skin symptoms, and help reduce steroid use in people with dermatomyositis or polymyositis. It may be an option if standard treatments haven't worked well enough.
Gainesville, FloridaAges 18 years+ - NCT07156916RecruitingPhase 1
Tamsulosin tablet comparison study in healthy men
This trial tests how a new tamsulosin tablet (used for prostate problems) compares to the standard drug in healthy men. You will take one dose and have blood samples taken to measure the drug levels.
Yerevan, Ankuk RegionAges 18–45 - NCT07159087Enrolling by invitation
New drug balloon for re-narrowed stents
This trial tests a new drug-coated balloon (Genoss SCB) versus an existing one (SeQuent Please NEO) for people whose heart stents have re-narrowed. It aims to see which balloon better keeps the artery open.
Gyeonggi-doAges 19 years+ - NCT07155187RecruitingPhase 2/Phase 3
Study of telisotuzumab adizutecan for EGFR-mutated lung cancer
This trial tests a new drug, telisotuzumab adizutecan (given through a vein), alone or with another targeted therapy, versus standard treatments for people with a specific type of advanced lung cancer that has an EGFR mutation and has gotten worse after previous treatment.
Springdale, ArkansasAges 18 years+ - NCT03509961RecruitingPhase 2
Reducing total body radiation for children with leukemia transplants
This study looks at whether some children and young adults with B-ALL can safely get a transplant without total body irradiation (TBI), based on special leukemia test results. It’s meant to help lower radiation-related risks while keeping leukemia control strong.
Birmingham, AlabamaAges 1–25 - NCT07155174RecruitingPhase 2
Testing new drug combo for first-line extensive small cell lung cancer
This trial tests a new combination treatment (ABBV-706 plus atezolizumab) as a first option for people with extensive stage small cell lung cancer. It compares this new approach to the usual standard treatment, aiming to see if it works better and has fewer side effects.
New Haven, ConnecticutAges 18 years+ - NCT07151742Enrolling by invitation
Exercise during dialysis for muscle health
This study tests whether exercise during hemodialysis can improve muscle oxygen levels and how well dialysis works. It is for people who have been on dialysis for at least a year and have muscle loss (sarcopenia).
Istanbul, KadikoyAges 18–65 - NCT07145294RecruitingPhase 1/Phase 2
Stem cell therapy to improve thinking after stroke
This trial tests whether tiny particles from stem cells can help people recover thinking and memory after a recent stroke. Doctors will check if the treatment is safe and if it boosts brain function.
ShanghaiAges 18 years+ - NCT07149701Recruiting
Ventricular Tachycardia patient registry study
This study is for adults with ventricular tachycardia (a fast heart rhythm) who also have structural heart disease. It will track your health over time to learn more about how this condition is managed.
BeijingAges 18 years+ - NCT07153068RecruitingPhase 1/Phase 2
SupCD7 CART therapy for CD7 positive blood cancers
This trial tests a special immune cell therapy (SupCD7 CART) that targets a protein called CD7 on cancer cells. It is for people with certain types of blood cancers (like T-ALL/LBL or AML) that have come back or not responded to standard treatments.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT06959628Recruiting
Study of a new shunt system for carotid artery blockage treatment
This trial tests a special shunt system to protect your brain during carotid artery stenting. It may help people with severe blockages in the neck artery that supplies blood to the brain.
BeijingAges 18 years+ - NCT05470127Recruiting
Testing a new prostate biopsy needle against the usual one
This study compares a new prostate biopsy system/needle with the standard biopsy needle during your scheduled prostate biopsy. It looks at how well the procedure collects tissue for diagnosis and how the tissue samples compare.
Cartersville, GeorgiaAges 18–90 - NCT05009758Recruiting
Asthma and nasal polyps study to match immune patterns
This study looks at different “immune inflammation patterns” in people with asthma and/or nasal polyps. It may help researchers better tailor future treatments by figuring out which patterns go with which symptoms.
ViennaAges 18–99 - NCT06081075Recruiting
Newborn Genomics Program for Sick Infants
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
AucklandAges birth–2 years
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,559 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.